Related Experiment Video
Updated: Sep 9, 2025

11:36
A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
Published on: April 28, 2016
9.4K
Lipids Engage a Kidney-Brain GDF15 Axis to Suppress Food Intake
Ameth N Garrido1,2, Song-Yang Zhang1, Kyla Bruce1,3
1Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Diabetes
|August 28, 2025
Summary
Upper small intestine lipid infusion impacts growth differentiation factor 15 (GDF15) and food intake differently in rats based on diet. Kidney GDF15 and area postrema GFRAL are key in mediating these lipid-induced effects.
Area of Science:
- Metabolic signaling
- Gut-brain axis
- Hormonal regulation
Background:
- Lipid sensing in the upper small intestine influences systemic metabolism and feeding behavior.
- Growth differentiation factor 15 (GDF15) is implicated in appetite regulation and metabolic homeostasis.
- The role of GDF15 and its receptors in response to intestinal lipid loads requires further elucidation.
Purpose of the Study:
- To investigate the impact of upper small intestine lipid infusion on GDF15 levels and food intake in rats fed different diets.
- To determine the involvement of kidney-derived GDF15 and the GDNF family receptor α-like (Gfral) in the area postrema in mediating these responses.
Main Methods:
- Rats were fed either a chow or high-fat diet and received upper small intestine lipid infusions.
- Kidney Gdf15 or area postrema Gfral were knocked down using specific genetic techniques.
- Plasma and tissue GDF15 levels, along with food intake, were measured.
Main Results:
- Lipid infusion increased kidney, hepatic, and plasma GDF15 in chow-fed rats but not high-fat-fed rats.
- Food intake was reduced by lipid infusion in chow-fed rats, an effect blunted in high-fat-fed rats.
- Kidney Gdf15 knockdown abolished the lipid-induced increase in plasma GDF15 and the reduction in feeding.
- Area postrema Gfral knockdown negated the anorectic effect of lipid infusion.
Conclusions:
- Kidney GDF15 plays a crucial role in mediating the systemic GDF15 elevation and appetite suppression following upper small intestine lipid exposure.
- The area postrema GFRAL pathway is essential for sensing intestinal lipid signals to control feeding behavior.
- Diet composition significantly modulates the physiological responses to upper small intestine lipid loads.
Related Concept Videos
Regulation of Food Intake
350
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
350
Glomerular Filtration Rate and its Regulation
3.3K
The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
3.3K
Glucagon-like Receptor Agonists
416
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
416

